***Background.*** In January 2011, an electronic health record (EHR) based auto-stop feature, facilitated by mandatory antimicrobial order end dates, was enabled at our institution as part of an established Antimicrobial Stewardship Program (ASP). Previously, restricted antimicrobial orders remained as current medications in the EHR after the ASP-approved length of therapy (typically 48 hours) was complete. However another approval was required for the pharmacy to dispense more medication. Following the auto-stop implementation, the order expired from the current medications list after completion of the approved length of therapy.

***Methods.*** Repeated cross-sectional study to assess the impact of auto-stop on clinical outcomes of hospitalized children. Data on patients discharged between 2/1/2009 and 1/31/13 were obtained from the Pediatric Health Information System, a database containing medication billing data. A sub-cohort of patients with bacteremia was also identified using microbiology laboratory data. Outcomes included all-cause in-hospital mortality, readmission within 14-days and 30 days of discharge, and length of stay. Model-based pre-post comparisons were standardized by patient and clinical characteristics and accounted for clustering by physician.

***Results.*** During the 4-year study period, 26300 patients received restricted antibacterials. In-hospital all-cause mortality, 14-day and 30-day readmission, and length of stay were not significantly different before and after implementation of the auto-stop in all patients or the sub-cohort of children with bacteremia (table).

###### 

Standardized clinical outcomes for patients receiving restricted antibiotics

  ---------------------------------------------------------------------------------------------------------
                                       All Patients\   Bacteremia Patients\                         
                                       (n=26300)       (n=1405)                                     
  ------------------------------------ --------------- ---------------------- ------- ------ ------ -------
  Standardized Rate (%)                                                                             

   In-hospital all-cause mortality     2.0             1.9                    0.358   8.0    6.8    0.315

   Readmission in 14 days              7.4             7.5                    0.778   6.2    4.8    0.294

   Readmission in 30 days              15.4            16.4                   0.057   17.4   17.2   0.947

                                                                                                    

  Standardized Length of Stay (days)   11.7            12.0                   0.183   44.7   47.6   0.350
  ---------------------------------------------------------------------------------------------------------

***Conclusion.*** Implementation of an EHR-based antimicrobial auto-stop feature did not significantly impact clinical outcomes in hospitalized children. Future studies should examine the effects of this EHR-based tool on antimicrobial use.
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